newsfilter
← Latest News
ACCESS Newswire·

NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments

Completed concrete milestones in its strategy to become a leading psychedelic drug developer and specialty clinics operator. Developed clear drug development pathway for NEO-001, the industry's first psilocybin-based obesity treatment with near-term clin